ArticleBlood neoplasia2026
Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.